vs
Ascendis Pharma A/S（ASND）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Ascendis Pharma A/S的季度营收约是Rapid7, Inc.的1.2倍（$267.3M vs $217.4M），Ascendis Pharma A/S同比增速更快（42.3% vs 0.5%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 3.0%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
ASND vs RPD — 直观对比
营收规模更大
ASND
是对方的1.2倍
$217.4M
营收增速更快
ASND
高出41.8%
0.5%
两年增速更快
ASND
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $217.4M |
| 净利润 | — | $3.1M |
| 毛利率 | 90.5% | 68.9% |
| 营业利润率 | — | 1.0% |
| 净利率 | — | 1.4% |
| 营收同比 | 42.3% | 0.5% |
| 净利润同比 | — | 44.1% |
| 每股收益（稀释后） | — | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDRPD
| Q4 25 | $267.3M | $217.4M | ||
| Q3 25 | $230.7M | $218.0M | ||
| Q2 25 | $170.7M | $214.2M | ||
| Q1 25 | $109.0M | $210.3M | ||
| Q4 24 | $187.8M | $216.3M | ||
| Q3 24 | $62.5M | $214.7M | ||
| Q2 24 | $38.9M | $208.0M | ||
| Q1 24 | $103.6M | $205.1M |
净利润ASNDRPD
| Q4 25 | — | $3.1M | ||
| Q3 25 | $-65.9M | $9.8M | ||
| Q2 25 | $-42.0M | $8.3M | ||
| Q1 25 | $-102.2M | $2.1M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | $-107.1M | $15.4M | ||
| Q2 24 | $-118.1M | $6.5M | ||
| Q1 24 | $-141.5M | $1.4M |
毛利率ASNDRPD
| Q4 25 | 90.5% | 68.9% | ||
| Q3 25 | 89.5% | 70.2% | ||
| Q2 25 | 80.1% | 70.6% | ||
| Q1 25 | 82.6% | 71.7% | ||
| Q4 24 | 91.9% | 69.5% | ||
| Q3 24 | 80.6% | 70.6% | ||
| Q2 24 | 68.2% | 70.7% | ||
| Q1 24 | 92.1% | 70.3% |
营业利润率ASNDRPD
| Q4 25 | — | 1.0% | ||
| Q3 25 | 5.1% | 2.7% | ||
| Q2 25 | -33.5% | 1.6% | ||
| Q1 25 | -103.2% | -0.0% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | -167.3% | 6.0% | ||
| Q2 24 | -370.2% | 2.5% | ||
| Q1 24 | -51.2% | 4.7% |
净利率ASNDRPD
| Q4 25 | — | 1.4% | ||
| Q3 25 | -28.5% | 4.5% | ||
| Q2 25 | -24.6% | 3.9% | ||
| Q1 25 | -93.7% | 1.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | -171.5% | 7.2% | ||
| Q2 24 | -303.9% | 3.1% | ||
| Q1 24 | -136.6% | 0.7% |
每股收益（稀释后）ASNDRPD
| Q4 25 | — | $0.05 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | — | $0.09 | ||
| Q1 24 | — | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $154.7M |
| 总资产 | $1.4B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDRPD
| Q4 25 | $665.3M | $474.7M | ||
| Q3 25 | $582.2M | $407.1M | ||
| Q2 25 | $533.6M | $511.7M | ||
| Q1 25 | $559.4M | $493.5M | ||
| Q4 24 | $604.3M | $521.7M | ||
| Q3 24 | $675.6M | $443.7M | ||
| Q2 24 | $279.4M | $442.6M | ||
| Q1 24 | $345.9M | $411.7M |
股东权益ASNDRPD
| Q4 25 | $-175.8M | $154.7M | ||
| Q3 25 | $-188.0M | $127.2M | ||
| Q2 25 | $-202.6M | $90.4M | ||
| Q1 25 | $-205.0M | $52.7M | ||
| Q4 24 | $-114.2M | $17.7M | ||
| Q3 24 | $-105.1M | $-5.1M | ||
| Q2 24 | $-346.8M | $-52.6M | ||
| Q1 24 | $-257.2M | $-86.4M |
总资产ASNDRPD
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.3B | $1.7B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $819.0M | $1.5B | ||
| Q1 24 | $866.7M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.4M |
| 自由现金流率自由现金流/营收 | — | 16.8% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | — | $146.2M |
8季度趋势，按日历期对齐
经营现金流ASNDRPD
| Q4 25 | $58.2M | $37.6M | ||
| Q3 25 | — | $39.0M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | $-15.5M | $29.8M | ||
| Q4 24 | $-330.7M | $63.8M | ||
| Q3 24 | — | $44.0M | ||
| Q2 24 | — | $32.9M | ||
| Q1 24 | $-109.7M | $31.1M |
自由现金流ASNDRPD
| Q4 25 | — | $36.4M | ||
| Q3 25 | — | $34.8M | ||
| Q2 25 | — | $46.6M | ||
| Q1 25 | — | $28.4M | ||
| Q4 24 | — | $62.6M | ||
| Q3 24 | — | $42.6M | ||
| Q2 24 | — | $32.6M | ||
| Q1 24 | — | $30.4M |
自由现金流率ASNDRPD
| Q4 25 | — | 16.8% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 13.5% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 14.8% |
资本支出强度ASNDRPD
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.3% |
现金转化率ASNDRPD
| Q4 25 | — | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
